Inductive Bio

@inductive_bio

Inductive Bio accelerates compound optimization with state-of-the-art ADMET AI models and generative chemistry. inductive.bio

Joined December 2023

Following

434

Followers

Replies Reposts Media

Inductive Bio
@inductive_bio
Jun 11
We’re excited to share that Inductive Bio has joined the OASIS Consortium, a collaborative effort focused on predicting liver toxicity from advanced in vitro assays within the Health and Environmental Sciences Institute (HESI). As part of OASIS, we’ll be helping assess how
Inductive Bio
@inductive_bio
Feb 3
We are excited to announce we have won first place in the OpenADMET-ExpansionRx blind challenge - our second consecutive first-place finish in a major ADMET benchmark. This challenge had 370+ teams competing to predict 9 ADMET properties on over 2,250 unseen compounds from a
Inductive Bio
@inductive_bio
Dec 8, 2025
We’re excited to lead a $21M ARPA-H initiative with @Amgen and leading academics to build AI models for drug toxicity - improving drug safety and reducing reliance on animal testing. We’re generating human organoid, microphysiological system (MPS), and ex vivo tissue data to
Inductive Bio
@inductive_bio
Jul 11, 2025
Can AI fix one of drug discovery’s biggest bottlenecks? At Inductive Bio, we think so, by making ADMET optimization faster and smarter. In this new @DrugTargetRev feature, our CEO Josh Haimson shares how:
Fixing drug discovery’s most persistent problem with AI
From drugtargetreview.com
Inductive Bio
@inductive_bio
Jun 12, 2025
We’re thrilled to announce that our latest generation of Beacon-1 ADMET models secured first place in the recent @Polaris_HQ blinded prediction challenge focused on ADMET properties in a real ASAP discovery antiviral program. Read about our lessons learned:
inductive.bio
Lessons from the Polaris ADMET competition
Following our competition win, we explored what the competition results tell us about the state of ML for drug discovery